By Barrie av / Jan, 28 2026
Reimbursement and Coding for Biosimilars: How Billing Works Under Medicare Part B
Learn how biosimilars are billed under Medicare Part B, why providers still favor expensive reference drugs, and how coding rules like HCPCS codes and the JZ modifier impact reimbursement and adoption.
view more